SCHEMBL16586567

SCHEMBL16586567

COc1ncnc(OC)c1-c1ncn(C)n1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.34
AOC3 Q16853 2/20 0.32
FLT4 P35916 1/20 0.32
KDR P35968 1/20 0.32
PPARA Q07869 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CCR4 P51679 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30
F10 P00742 1/20 0.30
TYK2 P29597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16597072 0.76 PPARA (0.33) AOC3PPARAGABRA1GABRG2GABRB3
SCHEMBL16584083 0.74 NPC1 (0.34) PDPK1FLT4KDR
SCHEMBL20969942 0.73 PPARA (0.40) AOC3PPARAGABRA1GABRG2GABRB3
SCHEMBL7676249 0.70 HRH4 (0.36)
SCHEMBL16583426 0.68 PDE10A (0.33) FLT4KDR
SCHEMBL16583549 0.68 FLT4 (0.33) FLT4KDR
SCHEMBL13696876 0.68 CLK4 (0.53) AOC3ALDH1A1
SCHEMBL18076627 0.67 NPC1 (0.38) PDPK1ALDH1A1
SCHEMBL2629321 0.66
SCHEMBL16583445 0.65 ALDH1A1 (0.35) PDPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104418849-B Substituted aminopyrimidine compounds and use method and application thereof 广东东阳光药业有限公司 2020-04-21 CN disclosed
WO-2015042497-A2 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2015-03-26 WO disclosed
WO-2015042497-A2 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE CALITOR SCIENCES, LLC (US) 2015-03-26 WO disclosed